137 related articles for article (PubMed ID: 38395407)
1. Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes.
Baelen J; Dewaele B; Debiec-Rychter M; Sciot R; Schöffski P; Hompes D; Sinnaeve F; Wafa H; Vanden Bempt I
J Mol Diagn; 2024 May; 26(5):374-386. PubMed ID: 38395407
[TBL] [Abstract][Full Text] [Related]
2. Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping.
Neveling K; Mantere T; Vermeulen S; Oorsprong M; van Beek R; Kater-Baats E; Pauper M; van der Zande G; Smeets D; Weghuis DO; Stevens-Kroef MJPL; Hoischen A
Am J Hum Genet; 2021 Aug; 108(8):1423-1435. PubMed ID: 34237281
[TBL] [Abstract][Full Text] [Related]
3. Optical genome mapping enables constitutional chromosomal aberration detection.
Mantere T; Neveling K; Pebrel-Richard C; Benoist M; van der Zande G; Kater-Baats E; Baatout I; van Beek R; Yammine T; Oorsprong M; Hsoumi F; Olde-Weghuis D; Majdali W; Vermeulen S; Pauper M; Lebbar A; Stevens-Kroef M; Sanlaville D; Dupont JM; Smeets D; Hoischen A; Schluth-Bolard C; El Khattabi L
Am J Hum Genet; 2021 Aug; 108(8):1409-1422. PubMed ID: 34237280
[TBL] [Abstract][Full Text] [Related]
4. Detection of complex chromosome rearrangements using optical genome mapping.
Qu J; Li S; Yu D
Gene; 2023 Oct; 884():147688. PubMed ID: 37543218
[TBL] [Abstract][Full Text] [Related]
5. Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal Rearrangements.
Coccaro N; Zagaria A; Anelli L; Tarantini F; Tota G; Conserva MR; Cumbo C; Parciante E; Redavid I; Ingravallo G; Minervini CF; Minervini A; Specchia G; Musto P; Albano F
Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137002
[TBL] [Abstract][Full Text] [Related]
6. Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia.
Valkama A; Vorimo S; Kumpula TA; Räsänen H; Savolainen ER; Pylkäs K; Mantere T
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831635
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping.
Rack K; De Bie J; Ameye G; Gielen O; Demeyer S; Cools J; De Keersmaecker K; Vermeesch JR; Maertens J; Segers H; Michaux L; Dewaele B
Am J Hematol; 2022 May; 97(5):548-561. PubMed ID: 35119131
[TBL] [Abstract][Full Text] [Related]
8. Clinical Validation and Diagnostic Utility of Optical Genome Mapping in Prenatal Diagnostic Testing.
Sahajpal NS; Mondal AK; Fee T; Hilton B; Layman L; Hastie AR; Chaubey A; DuPont BR; Kolhe R
J Mol Diagn; 2023 Apr; 25(4):234-246. PubMed ID: 36758723
[TBL] [Abstract][Full Text] [Related]
9. Optical genome mapping in acute myeloid leukemia: a multicenter evaluation.
Levy B; Baughn LB; Akkari Y; Chartrand S; LaBarge B; Claxton D; Lennon PA; Cujar C; Kolhe R; Kroeger K; Pitel B; Sahajpal N; Sathanoori M; Vlad G; Zhang L; Fang M; Kanagal-Shamanna R; Broach JR
Blood Adv; 2023 Apr; 7(7):1297-1307. PubMed ID: 36417763
[TBL] [Abstract][Full Text] [Related]
10. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Optical Genome Mapping With Conventional Diagnostic Methods for Structural Variant Detection in Hematologic Malignancies.
Shim Y; Koo YK; Shin S; Lee ST; Lee KA; Choi JR
Ann Lab Med; 2024 Jul; 44(4):324-334. PubMed ID: 38433573
[TBL] [Abstract][Full Text] [Related]
12. Detection of cryptic balanced chromosomal rearrangements using high-resolution optical genome mapping.
Zhang S; Pei Z; Lei C; Zhu S; Deng K; Zhou J; Yang J; Lu D; Sun X; Xu C; Xu C
J Med Genet; 2023 Mar; 60(3):274-284. PubMed ID: 35710108
[TBL] [Abstract][Full Text] [Related]
13. [Fluorescence in situ hybridization for the diagnosis of soft-tissue and bone tumors].
Bertram S; Schildhaus HU
Pathologe; 2020 Nov; 41(6):589-605. PubMed ID: 32965532
[TBL] [Abstract][Full Text] [Related]
14. Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
Lestringant V; Duployez N; Penther D; Luquet I; Derrieux C; Lutun A; Preudhomme C; West M; Ouled-Haddou H; Devoldere C; Marolleau JP; Garçon L; Jedraszak G; Ferret Y
Genes Chromosomes Cancer; 2021 Oct; 60(10):657-667. PubMed ID: 33982372
[TBL] [Abstract][Full Text] [Related]
15. Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma.
Barford RG; Whittle E; Weir L; Fong FC; Goodman A; Hartley HE; Allinson LM; Tweddle DA
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958407
[TBL] [Abstract][Full Text] [Related]
16. Analytic Validation of Optical Genome Mapping in Hematological Malignancies.
Pang AWC; Kosco K; Sahajpal NS; Sridhar A; Hauenstein J; Clifford B; Estabrook J; Chitsazan AD; Sahoo T; Iqbal A; Kolhe R; Raca G; Hastie AR; Chaubey A
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137484
[TBL] [Abstract][Full Text] [Related]
17. EWSR1-NFATC2 Translocation-associated Sarcoma Clinicopathologic Findings in a Rare Aggressive Primary Bone or Soft Tissue Tumor.
Wang GY; Thomas DG; Davis JL; Ng T; Patel RM; Harms PW; Betz BL; Schuetze SM; McHugh JB; Horvai AE; Cho SJ; Lucas DR
Am J Surg Pathol; 2019 Aug; 43(8):1112-1122. PubMed ID: 30994538
[TBL] [Abstract][Full Text] [Related]
18. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
[TBL] [Abstract][Full Text] [Related]
19. Optical Genome Mapping as a Next-Generation Cytogenomic Tool for Detection of Structural and Copy Number Variations for Prenatal Genomic Analyses.
Sahajpal NS; Barseghyan H; Kolhe R; Hastie A; Chaubey A
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33799648
[TBL] [Abstract][Full Text] [Related]
20. EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene.
Antonescu CR; Zhang L; Chang NE; Pawel BR; Travis W; Katabi N; Edelman M; Rosenberg AE; Nielsen GP; Dal Cin P; Fletcher CD
Genes Chromosomes Cancer; 2010 Dec; 49(12):1114-24. PubMed ID: 20815032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
